Mehta Yatin, Chaudhry Dhruva, Abraham O C, Chacko Jose, Divatia Jigeeshu, Jagiasi Bharat, Kar Arindam, Khilnani G C, Krishna Bhuvana, Kumar Prashant, Mani R K, Rao B K, Singh Pawan K, Singh Sanjeev, Tiwary Pavan, Wattal Chand, Govil Deepak, Dixit Subhal, Samavedam Srinivas
Department of Critical Care and Anesthesiology, Medanta: The Medicity, Gurugram, Haryana, India.
Department of Pulmonary and Critical Care, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.
Indian J Crit Care Med. 2020 Nov;24(Suppl 5):S225-S230. doi: 10.5005/jp-journals-10071-23621.
The management of coronavirus disease-2019 (COVID-19) is witnessing a change as we learn more about the pathophysiology and the severity of the disease. Several randomized controlled trials (RCTs) and meta-analysis have been published over the last few months. Several interventions and therapies which showed promise in the initial days of the pandemic have subsequently failed to show benefit in well-designed trials. Understanding of the methods of oxygen delivery and ventilation have also evolved over the past few months. The Indian Society of Critical Care Medicine (ISCCM) has reviewed the evidence that has emerged since the publication of its position statement in May and has put together an addendum of updated evidence. Mehta Y, Chaudhry D, Abraham OC, Chacko J, Divatia J, Jagiasi B, . Critical Care for COVID-19 Affected Patients: Position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med 2020;24(Suppl 5):S225-S230.
随着我们对2019冠状病毒病（COVID-19）的病理生理学和疾病严重程度有了更多了解，其治疗方法正在发生变化。在过去几个月里，已经发表了几项随机对照试验（RCT）和荟萃分析。在疫情初期显示出前景的几种干预措施和疗法，随后在精心设计的试验中未能显示出益处。在过去几个月里，对氧输送和通气方法的理解也有所发展。印度危重病医学会（ISCCM）审查了自其5月份立场声明发表以来出现的证据，并汇编了一份最新证据附录。梅塔Y、乔杜里D、亚伯拉罕OC、查科J、迪瓦蒂亚J、贾贾西B等。COVID-19感染患者的重症监护：印度危重病医学会的立场声明。《印度重症监护医学杂志》2020年；24（增刊5）：S225-S230。
